Gross JM, Suster DI, Zou Y, Mata DA, Amary F, De Noon S, Flanagan AM, Wakeman KM, Wangsiricharoen S, Dong F, Lam SW, Bovée JVMG, Baltres A, Pissaloux D, Pasmant E, Larousserie F, Miettinen M, Hameed M, Charville GW. Expanding the Clinicopathologic Spectrum of EWSR1::SSX-Rearranged Sarcomas: Series of 11 Cases Including Osteosarcomas and a Novel EWSR1::SSX4 Fusion. Mod Pathol. 2025 Oct 24;39(1):100922. doi: 10.1016/j.modpat.2025.100922. Epub ahead of print. PM
Lu Z, Smith BF, Wakeman KM, Shackleton D, Elkind J, Angel MR, Suciu CG, Neff T, Beadling C, Wangsiricharoen S. Sarcoma harbouring CEP170::RAD51B fusion: a case report emphasizing diagnostic caution in low-read, pseudogene-associated rearrangements. Histopathology. 2025 Jun 17. doi: 10.1111/his.15477. Epub ahead of print. PMID: 40525276.
Argani P, Wangsiricharoen S, Tretiakova M, Liu YJ, Falzarano SM, Collins K, Brimo F, Gross JM, Baraban E, Matoso A, Wakeman KM, Corless C, Neff T, Smith BF, Abdel Satir A, Agaimy A, Antonescu CR, Charville GW, Sangoi AR. MEIS1::NCOA1 Primitive Spindle Cell Sarcoma of the Kidney : Report of 7 Cases of a Distinctive Clinicopathologic Entity. Am J Surg Pathol. 2025 Jun 1;49(6):620-632. doi: 10.1097/PAS.0000000000002386. Epub 2025 Mar 31. PMID: 40160183.
Davis L, Zhu L, Mayo SC, Latour E, Park B, Huang W, Moloney B, Davis JL, Wakeman KM, Sheppard B, Billingsley KG, Vetto J, Valenzuela CD, Eil RL, Rocha F, Hung A, Ryan CW. Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study. Res Sq [Preprint]. 2024 Dec 17:rs.3.rs-5397300. doi: 10.21203/rs.3.rs-5397300/v1. PMID: 39764100; PMCID: PMC11702773.
Terry M, Wakeman KM, Williams BJ, Miller DM, Sak M, Abdullaev Z, Pacheco MC, Aldape K, Lehman NL. Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutations. Free Neuropathol. 2022 Aug 26;3:21. doi: 10.17879/freeneuropathology-2022-3864. PMID: 37284154; PMCID: PMC10209877.
Kao EY, Wakeman KM, Wu Y, Gross JM, Chen EY, Ricciotti RW, Liu YJ, Mantilla JG. Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR. Hum Pathol. 2022 Nov;129:90-97. doi: 10.1016/j.humpath.2022.08.005. Epub 2022 Sep 5. PMID: 36067829.
Wakeman KM, Zhang QS, Bandhlish A, Cranmer LD, Ricciotti RW, Mantilla JG. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors. Am J Clin Oncol. 2022 Jan 1;45(1):28-35. doi: 10.1097/COC.0000000000000877. PMID: 34962906.